Dermatology Biotech Bambusa Dips 6.3% After $168.9 Million IPO
Source Bloomberg 财经2d ago
Summary
Bambusa Therapeutics Inc. shares slipped 6.3% in its trading debut after the early-stage biotech focused on dermatology and autoimmune diseases raised $168.9 m…
We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.
Open original- Desk
- Business
- Region
- Americas
- Language
- English
- Item ID
- business-e7acff41
Comments 0 comments
No comments yet. Be the first.